Tagged: Drug Development

Antifungal Resistance: A Global Health Threat

Antibiotic resistance receives lots of media attention, being a huge threat to global public health. But an equally concerning problem remains a relative unknown to the general public: antifungal resistance. Fungal infections have the potential to cause rashes, mild inflammations,...

monoclonal antibodies antigen binding protein interaction

Monoclonal Antibodies in Drug Development

The global monoclonal antibody market has an annual value of USD 100 billion, boasting blockbuster drugs such as Humira and Keytruda. Monoclonal antibodies are immune cells that have the ability to bind to very specific targets. By doing so, they...